EyePoint Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2010 to Q1 2025.
  • EyePoint Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was $39.5M, a 90% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$219M, a 6517% decline from 2023.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$3.32M, a 80.8% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$17.3M, a 47.9% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

EyePoint Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $39.5M +$18.7M +90% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $20.8M -$11.3M -35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $32.1M +$88.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$56.4M -$56.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $0 +$16K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 -$16K +$166K +91.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 -$182K +$14.9M +98.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 -$109K -$45K -70.3% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q1 2018 -$15.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 -$64K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q3 2013 $1.44M +$795K +123% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-13
Q3 2012 $647K +$1.2M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q3 2011 -$552K +$2.62M +82.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 -$3.18M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-09

EyePoint Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$219M -$216M -6517% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$3.32M +$14M +80.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$17.3M +$15.9M +47.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$33.1M -$32.8M -9049% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$362K -$149K -70% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$213K +$16.7M +98.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$16.9M -$30.5M -224% Jul 1, 2017 Jun 30, 2018 10-K 2020-03-16
2017 $13.6M +$18M Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 -$4.46M Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2013 $6.36M +$5.75M +949% Jul 1, 2012 Jun 30, 2013 10-K 2013-09-27
2012 $606K +$10.1M Jul 1, 2011 Jun 30, 2012 10-K 2013-09-27
2011 -$9.5M -$7.43M -359% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 -$2.07M Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.